A new trading day began on Tuesday, with PMV Pharmaceuticals Inc (NASDAQ: PMVP) stock price up 12.26% from the previous day of trading, before settling in for the closing price of $1.06. PMVP’s price has ranged from $0.81 to $1.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -35.96%. With a float of $43.75 million, this company’s outstanding shares have now reached $51.95 million.
Let’s determine the extent of company efficiency that accounts for 47 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
PMV Pharmaceuticals Inc (PMVP) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of PMV Pharmaceuticals Inc is 15.79%, while institutional ownership is 67.72%. The most recent insider transaction that took place on Sep 11 ’24, was worth 10,853. In this transaction Chief Development Officer of this company sold 7,218 shares at a rate of $1.50, taking the stock ownership to the 118,283 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Chief Financial Officer sold 2,891 for $1.50, making the entire transaction worth $4,347. This insider now owns 88,395 shares in total.
PMV Pharmaceuticals Inc (PMVP) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -35.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.79% during the next five years compared to -14.06% drop over the previous five years of trading.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators
Here are PMV Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 16.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of PMV Pharmaceuticals Inc (PMVP)
Looking closely at PMV Pharmaceuticals Inc (NASDAQ: PMVP), its last 5-days average volume was 0.44 million, which is a jump from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 91.10%. Additionally, its Average True Range was 0.07.
During the past 100 days, PMV Pharmaceuticals Inc’s (PMVP) raw stochastic average was set at 58.02%, which indicates a significant decrease from 97.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.51% in the past 14 days, which was higher than the 56.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9545, while its 200-day Moving Average is $1.3529.
